Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple SclerosisJelle Y. Broos, Gijs Kooij, Helga E. de Vries et al.|Neurology|2023Cited by 24
Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple SclerosisFloor C. Loonstra, Joep Killestein, Lodewijk R. J. de Ruiter et al.|Neurology Neuroimmunology & Neuroinflammation|2022Cited by 18
Adipokines in multiple sclerosis patients are related to clinical and radiological measuresFloor C. Loonstra, Merel Rijnsburger, Kim Falize et al.|Journal of Neurology|2022Cited by 15
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohortLodewijk R. J. de Ruiter, Bernard M.J. Uitdehaag, Floor C. Loonstra et al.|Multiple Sclerosis and Related Disorders|2023Cited by 11
The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohortFloor C. Loonstra, Bernard M.J. Uitdehaag, Lodewijk R. J. de Ruiter et al.|Annals of Clinical and Translational Neurology|2023Cited by 11